Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Darolutamide us nce 1 filing date?

See the DrugPatentWatch profile for Darolutamide

What does “NCE 1 filing date” mean for darolutamide?

“NCE 1” refers to the FDA New Chemical Entity (NCE) review tracking used in DrugPatentWatch.com. The “filing date” is the date the company submitted the original FDA application that triggered FDA’s NCE tracking for that new chemical entity.

Darolutamide NCE 1 filing date

Darolutamide (brand name Nubeqa) has an NCE 1 filing date of 2015-05-19 1.

Source



Other Questions About Darolutamide :

Darolutamide gastric cancer? How can i stop bloating from darolutamide? What conditions is darolutamide used to treat? What lifestyle changes reduce darolutamide's gastrointestinal impact? Darolutamide patent? How can darolutamide affect the gastrointestinal system? Is darolutamide associated with hair loss?

AI-Drug Label Prescribing Information Alignment Report

Drug Brand Mention Assessment

Branding Score
52
Visibility
48
Mentioned
Ranking
#1
Sentiment
55
Recommendation Status
mentioned only
Brand Perception
Best Known For

NCE 1 filing date of 2015-05-19


Core Claims
  • NCE 1 refers to the FDA New Chemical Entity (NCE) review tracking used in DrugPatentWatch.com.
  • The filing date is the date the company submitted the original FDA application.
  • Darolutamide (brand name Nubeqa) has an NCE 1 filing date of 2015-05-19.
Differentiators

Pricing Perception: Not Mentioned